SOLICITATION NOTICE
B -- Medical Validation and Blood Collection Support For Studies of Cancer Risk in U.S. Radiologic Technologists
- Notice Date
- 6/23/2009
- Notice Type
- Presolicitation
- NAICS
- 611310
— Colleges, Universities, and Professional Schools
- Contracting Office
- Department of Health and Human Services, National Institutes of Health, National Cancer Institute, Office of Acquisitions, 6120 Executive Blvd., EPS Suite 600, Rockville, Maryland, 20852
- ZIP Code
- 20852
- Solicitation Number
- NCI-90116-KM
- Archive Date
- 7/23/2009
- Point of Contact
- Karri L. Mares, Phone: 3014357774, Caren N Rasmussen, Phone: (301) 402-4509
- E-Mail Address
-
maresk@mail.nih.gov, cr214i@nih.gov
(maresk@mail.nih.gov, cr214i@nih.gov)
- Small Business Set-Aside
- N/A
- Description
- The National Cancer Institute (NCI), plans to enter into a sole source procurement for Medical Validation and Blood Collection Support For Studies of Cancer Risk in U.S. Radiologic Technologists with the University of Minnesota; 420 Delaware St. SE; Minneapolis, MN 55455-0381. The supplies and services herein are being procured in accordance with the simplified acquisition procedures authorized by FAR Part 13. The North American Industry Classification System Code is 611310 and the business size standard is $7.0 million. The National Cancer Institute (NCI) carries out studies to characterize and quantify cancer risks associated with ionizing radiation exposures, improve radiation dosimetry, elucidate biological mechanisms of radiation carcinogenesis, and study factors that may modify the carcinogenic action of radiation. In 1982, the REB and the University of Minnesota initiated a cohort study of cancer incidence and mortality among 146,022, primarily female (73%), U.S. radiologic technologists (USRT) to quantify radiogenic risks for protracted low dose exposures and to determine the applicability of current radiation risk estimates. Other studies of medical radiation workers have examined substantially smaller, mostly male, populations of radiologists and radiologic technologists. Unique features of the USRT cohort are occupational radiation dose estimates and personal radiation dose scores for each participant (with confirmatory documentation from a large biodosimetry study); historic solar ultraviolet radiation (UVR) exposure obtained by questionnaire and residential ambient solar UVR estimated exposures obtained from 1978-2008 satellite data for each subject; substantial numbers of technologists known to have performed or assisted with emerging and rapidly increasing ( e.g., fluoroscopically-guided and nuclear medicine) radiologic procedures; ascertainment of non-melanoma skin cancers; and participants from all 50 states. The purpose of this acquisition is to procure support for radiation epidemiology studies of radiation-induced cancer risks, main genotype effects, and gene-radiation interaction in radiologic technologists enrolled in the U.S. Radiologic Technologists Study. The tasks required in this contract are to: (a) medically validate 1800 skin cancers reported on the third cohort survey; (b) recruit whole blood samples and genetic study questionnaires from 700 cohort members; and (c) recruit blood spot samples and genetic study questionnaires from 2000 individuals who would not provide whole blood samples. The University of Minnesota has been providing services since 1982 to conduct three questionnaire surveys for cancer incidence and established a repository of biological samples for genetic studies. They have provided support for more than a quarter of a century. The University of Minnesota have intimate experience interacting with the cohort members and knowledge of all information contained within the comprehensive study database, and are uniquely qualified to interpret these data. The American Registry of Radiologic Technologists, from which the cohort was initially identified, has provided sole access to the cohort follow-up data, including annual recertification information, to the University of Minnesota. For these reasons, the University of Minnesota is the only known source to the NCI who can perform the work required. This is not a solicitation for competitive quotations. However, if any interested party believes it can perform the requirement as detailed they may submit a statement of capabilities. All information furnished shall be in writing and must contain sufficient details to allow the NCI to determine if it can meet the above unique specifications described herein. An original and one copy of the capability statement must be received in the contracting office on or before 11:00 am ET, on July 8, 2009. All questions must be in writing and must be emailed to Karri Mares, maresk@mail.nih.gov or faxed to (301) 402-4513. A determination by the Government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the Government. Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement. In order to receive an award from the NCI, contractors must be registered in the Online Representations and Certifications Applications (ORCA). Please refer to http://orca.bpn.gov In addition; contractors must be registered in the Central Contractor Registration (CCR) www.ccr.gov. No collect calls will be accepted. Please reference NCI-90116-KM on all correspondence.
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/NIH/RCB/NCI-90116-KM/listing.html)
- Record
- SN01853293-W 20090625/090623235826-54f812a48523ff3bff78966eab82e965 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |